IMDX · Insight Molecular Diagnostics Inc. · Exempt Offerings
$2.83
-0.01 (-0.35%)
At close · Oct 23
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 10, 2026
The latest filing states the doubt was alleviated.
“Our expectation to generate operating losses and negative operating cash flows in the future and the need for additional funding to support our planned operations raise substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that the consolidated financial statements are issued. ... Management has concluded that it is probable that our plans will be effectively implemented and that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about our ability to continue as a going concern within one year after the date of issuance of these consolidated financial statements. ... Accordingly, management has concluded that substantial doubt does not exist about the Company's ability to continue as a going concern for a period of at least one year from the date of issuance of these consolidated financial statements.”View the 10-Q filed Aug 10, 2026
Market Cap
$92.61M
Shares
32.72M
Volume · Oct 23
42.48K
Avg daily vol (3M)
241.66K
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2025-02-24 | New | Biotechnology | $21,743,597 | $21,743,597 | 06b |
| 2024-10-08 | New | Biotechnology | $10,204,262 | $10,204,262 | 06b |
| 2024-04-25 | New | Biotechnology | $15,807,692 | $15,807,692 | 06b |
| 2021-04-29 | New | Biotechnology | $17,500,000 | $3,006,577 | 06b |
| 2021-03-08 | New | Biotechnology | $5,000,000 | $5,000,000 | 06b |
| 2020-02-11 | New | Biotechnology | $11,000,000 | $5,000,000 | 06b |
Showing 1–6 of 6 filings